Search Results - "Adler, Julia M"
-
1
Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding
Published in Cell reports (Cambridge) (03-08-2021)“…Safe and effective vaccines are urgently needed to stop the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We construct a…”
Get full text
Journal Article -
2
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Published in Nature communications (02-02-2024)“…The development of effective SARS-CoV-2 vaccines has been essential to control COVID-19, but significant challenges remain. One problem is intramuscular…”
Get full text
Journal Article -
3
Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence
Published in Viruses (08-10-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected almost 200 million people worldwide and led to approximately 4 million deaths as of…”
Get full text
Journal Article -
4
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters
Published in mBio (26-04-2022)“…Combinations of direct-acting antivirals are needed to minimize drug resistance mutations and stably suppress replication of RNA viruses. Currently, there are…”
Get full text
Journal Article -
5
Single-cell-resolved interspecies comparison shows a shared inflammatory axis and a dominant neutrophil-endothelial program in severe COVID-19
Published in Cell reports (Cambridge) (25-06-2024)“…A key issue for research on COVID-19 pathogenesis is the lack of biopsies from patients and of samples at the onset of infection. To overcome these hurdles,…”
Get full text
Journal Article -
6
In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs ® 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2
Published in Frontiers in pharmacology (26-07-2023)“…The occurrence of immune-evasive SARS-CoV-2 strains emphasizes the importance to search for broad-acting antiviral compounds. Our previous study showed that…”
Get full text
Journal Article -
7
Improving the Antigenicity of SARS-CoV-2 Vaccine Genes by Merging Mutations from Different Variants of Concern
Published in Vaccines (Basel) (27-02-2024)“…During the COVID-19 pandemic, the early emergence of viral variants repeatedly undermined the effects of vaccination. Our aim here is to explore strategies for…”
Get full text
Journal Article -
8
Early protective effect of a ("pan") coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration
Published in Frontiers in immunology (13-07-2023)“…The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted the danger posed by…”
Get full text
Journal Article -
9
Deciphering the Role of Humoral and Cellular Immune Responses in Different COVID-19 Vaccines-A Comparison of Vaccine Candidate Genes in Roborovski Dwarf Hamsters
Published in Viruses (16-11-2021)“…With the exception of inactivated vaccines, all SARS-CoV-2 vaccines currently used for clinical application focus on the spike envelope glycoprotein as a…”
Get full text
Journal Article -
10
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
Published in iScience (21-04-2023)“…The recurrent emerging of novel viral variants of concern (VOCs) with evasion of preexisting antibody immunity upholds severe acute respiratory syndrome…”
Get full text
Journal Article -
11
Virus-induced senescence is a driver and therapeutic target in COVID-19
Published in Nature (London) (11-11-2021)“…Derailed cytokine and immune cell networks account for the organ damage and the clinical severity of COVID-19 (refs. 1 – 4 ). Here we show that SARS-CoV-2,…”
Get full text
Journal Article -
12
A non-transmissible live attenuated SARS-CoV-2 vaccine
Published in Molecular therapy (02-08-2023)“…Live attenuated vaccines (LAVs) administered via the mucosal route may offer better control of the COVID-19 pandemic than non-replicating vaccines injected…”
Get full text
Journal Article -
13
Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics
Published in Molecular therapy (04-05-2022)“…For coronavirus disease 2019 (COVID-19), effective and well-understood treatment options are still scarce. Since vaccine efficacy is challenged by novel…”
Get full text
Journal Article -
14
Functionalized Fullerene for Inhibition of SARS‐CoV‐2 Variants
Published in Small (Weinheim an der Bergstrasse, Germany) (01-04-2023)“…As virus outbreaks continue to pose a challenge, a nonspecific viral inhibitor can provide significant benefits, especially against respiratory viruses…”
Get full text
Journal Article -
15
Mucus‐Inspired Self‐Healing Hydrogels: A Protective Barrier for Cells against Viral Infection
Published in Advanced materials (Weinheim) (01-08-2024)“…Mucus is a dynamic biological hydrogel, composed primarily of the glycoprotein mucin, exhibits unique biophysical properties and forms a barrier protecting…”
Get full text
Journal Article -
16
Mucin‐Inspired Single‐Chain Polymer (MIP) Fibers as Potent SARS‐CoV‐2 Inhibitors
Published in Angewandte Chemie International Edition (17-07-2023)“…Mucins are the key component of the defensive mucus barrier. They are extended fibers of very high molecular weight with diverse biological functions depending…”
Get full text
Journal Article -
17
Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants
Published in Proceedings of the National Academy of Sciences - PNAS (06-08-2024)“…Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) has developed substantial antigenic variability. As the majority of the population now has…”
Get full text
Journal Article -
18
Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)
Published in Science advances (03-12-2021)“…Vaccines are instrumental and indispensable in the fight against the COVID-19 pandemic. Several recent SARS-CoV-2 variants are more transmissible and evade…”
Get full text
Journal Article -
19
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
Published in Nature microbiology (01-05-2023)“…Vaccines play a critical role in combating the COVID-19 pandemic. Future control of the pandemic requires improved vaccines with high efficacy against newly…”
Get full text
Journal Article -
20
Neural network-assisted humanisation of COVID-19 hamster transcriptomic data reveals matching severity states in human disease
Published in EBioMedicine (01-10-2024)“…Translating findings from animal models to human disease is essential for dissecting disease mechanisms, developing and testing precise therapeutic strategies…”
Get full text
Journal Article